Sinusitis
📧 Sign up to get email alerts when something new happens for Sinusitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2023-08-09Clinical Trial Update: Pre-operative Steroids in CRSsP [Phase 2, Phase 3]
Clinical trial investigating pre-operative steroids in chronic rhinosinusitis with polyps was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-01-14Clinical Trial Update: Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates [Phase 2, Phase 3]
A clinical trial evaluating budesonide irrigations in chronic rhinosinusitis has been withdrawn (Phase 2/Phase 3).
-
CLINICAL_TRIALS withdrawal · 2020-04-02Clinical Trial Update: Chronic Rhinosinusitis With or Without Nasal Polyps Steroid Study [Phase 4]
Phase 4 trial for chronic rhinosinusitis with or without nasal polyps was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-02-05Clinical Trial Update: Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis [Phase 4]
Clinical trial evaluating omalizumab for chronic sinusitis was withdrawn after Phase 4.
-
EMA withdrawal · 2019-06-19EMA Withdrawn: Ketek (telithromycin) — Aventis Pharma S.A.
Telithromycin (Ketek) has been withdrawn from the European market by Aventis Pharma S.A. after regulatory assessment.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-05-01Clinical Trial Update: Vitamin D Supplementation in Chronic Rhinosinusitis With Nasal Polyps [NA]
The clinical trial evaluating vitamin D supplementation for chronic rhinosinusitis with nasal polyps has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-07Clinical Trial Update: A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions [Phase 1]
A Phase 1 bioequivalence study comparing SKF101804 cefixime to a cefixime reference formulation in healthy adults under fasting conditions h…
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: Pulmozyme in Cystic Fibrosis With Sinusitis [Phase 3]
Phase 3 trial of Pulmozyme for cystic fibrosis with sinusitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-06Clinical Trial Update: Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery [Phase 2]
Phase 2 trial investigating directed high-dose nasal corticosteroids for residual smell loss after sinus surgery was withdrawn.
-
EMA withdrawal · 2016-04-01CMDh endorses revocation of authorisations for fusafungine sprays used to treat airway infections
The CMDh endorses the revocation of authorisations for fusafungine nasal sprays and oral sprays used to treat airway infections due to safet…
-
CLINICAL_TRIALS withdrawal · 2012-04-13Clinical Trial Update: Pilot Study To Evaluate A Pharmacologically Active Nasal Sponge Following Endoscopic Sinus Surgery [NA]
A pilot study evaluating a pharmacologically active nasal sponge following endoscopic sinus surgery was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-02-17Clinical Trial Update: Nasospore Stent For Use in Enodscopic Sinus Surgery [Phase 4]
A Phase 4 trial evaluating the Nasospore Stent for endoscopic sinus surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-09-03Clinical Trial Update: The Effect of Tranexamic Acid on Intraoperative and Post-Operative Bleeding in Functional Endoscopic Sinus Surgery [NA]
A clinical trial evaluating tranexamic acid for reducing intraoperative and postoperative bleeding in functional endoscopic sinus surgery ha…
-
EMA withdrawal · 2008-02-14EMA Withdrawn: Levviax (telithromycin) — Aventis Pharma S.A.
Telithromycin (Levviax) has been withdrawn from the market by Aventis Pharma S.A. for community-acquired infections including pharyngitis, b…
-
EMA withdrawal · 2007-07-26EMA Application withdrawn: Garenoxacin mesylate — Schering-Plough Europe
The EMA application for garenoxacin mesylate by Schering-Plough Europe was withdrawn.